ftInvstr
PANACEABIO · Healthcare ₹380.1 -2.55% Mkt Cap ₹2328 Cr
← Search another stock

PANACEABIO

Healthcare Biotechnology
★ Watchlist ⧉ Add to bucket
₹380.1
-2.55% today · 30d -9.31%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for PANACEABIO. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹200 Cr
+19.72% YoY
NET PROFIT
₹2 Cr
-44.44% YoY
OPM
4.86%
+2.26pp YoY
EPS
₹0.38
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.6% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
PANACEABIO—-5.0
BIOCON154.516.88
ANTHEM91.3531.1
ONESOURCE—5.79
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
46
SCORE / 100
Overall
6-axis composite of the sections below.
Performance NEUTRAL 40
Valuation — —
Growth STEADY 58
Profitability LOW 18
Technicals WEAK 33
Risk LOW 80
Key Stats
P/B
2.95
52W HIGH
₹647.0
OFF HIGH
-41.25%
MKT CAP
₹2328 Cr
◉ Active Signals
MACDNeutral1.2846
RSI(14)Bearish34.05
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold PANACEABIO and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.